How Does Ezetimibe Work? Mechanism of Action Explained in Plain English

If your doctor has prescribed ezetimibe, you might be wondering: how is this different from the cholesterol medication I've heard of before — statins? The answer comes down to where in the body each drug acts, and that difference is both medically significant and surprisingly intuitive once it's explained clearly.

First, a Quick Lesson on Cholesterol

Cholesterol in your bloodstream comes from two sources: your liver makes it (called endogenous cholesterol), and your small intestine absorbs it from food and from bile (called exogenous or dietary cholesterol). Your liver actually makes most of your cholesterol — dietary intake accounts for roughly 25-30% of total cholesterol in the body, while the liver produces the rest through a process called synthesis.

Most cholesterol-lowering drugs either reduce the liver's production of cholesterol (statins, bempedoic acid) or increase the liver's removal of LDL from the bloodstream (PCSK9 inhibitors). Ezetimibe takes a third approach: it reduces how much cholesterol is absorbed in the small intestine before it even reaches the liver.

How Ezetimibe Works: The NPC1L1 Transporter

NPC1L1 transporter (Niemann-Pick C1-Like 1 protein). This protein acts like a gatekeeper — it sits on the surface of intestinal cells and actively pulls cholesterol molecules from the contents of your intestine into the intestinal cell, where it can then pass into your bloodstream.

Ezetimibe selectively binds to and blocks the NPC1L1 transporter. With the transporter blocked, cholesterol from your diet — and from bile that your liver secretes into the intestine — cannot be efficiently absorbed into the intestinal cells. Instead, it passes through the intestine and is excreted in the stool.

This process is highly selective. Ezetimibe inhibits cholesterol absorption by approximately 54%, while having no effect on the absorption of triglycerides, fatty acids, bile acids, or fat-soluble vitamins (A, D, and E). This selectivity is one reason ezetimibe has such a clean side effect profile.

What Happens in the Liver as a Result

When ezetimibe reduces the amount of cholesterol reaching the liver from the intestine, the liver senses a drop in its cholesterol supply. In response, it upregulates LDL receptors on its surface — essentially increasing the number of "docking stations" that grab LDL cholesterol particles out of the bloodstream and bring them into the liver for processing.

This is why ezetimibe effectively lowers blood LDL levels even though it works in the intestine, not the bloodstream. The liver compensates for reduced intestinal cholesterol delivery by clearing more LDL from circulation.

Why Ezetimibe and Statins Work Well Together

Statins work by blocking an enzyme called HMG-CoA reductase in the liver, which reduces the liver's own production of cholesterol. Interestingly, statins can partially counteract their own effectiveness: when the liver makes less cholesterol, it may also increase intestinal cholesterol absorption to compensate.

This is where ezetimibe's complementary mechanism comes in. By blocking intestinal absorption at the same time that a statin blocks liver production, the two drugs attack cholesterol from two different directions. The result is a reduction in LDL cholesterol that is greater than either drug achieves alone — typically an additional 21-27% LDL reduction when ezetimibe is added to a statin.

Ezetimibe's Pharmacokinetics: How the Drug Moves Through Your Body

After you take ezetimibe orally, it is absorbed from the intestine and quickly converted to its active form, ezetimibe-glucuronide, in the liver (a process called glucuronidation). This active metabolite travels through the bile back into the intestine, where it can be reabsorbed — a process called enterohepatic recycling. This recycling is what gives ezetimibe its unusually long half-life of approximately 22 hours, allowing for once-daily dosing.

Ezetimibe reaches peak plasma concentrations within 4-12 hours of oral administration. Both ezetimibe and its active metabolite are more than 90% bound to plasma proteins. The drug is eliminated primarily through the feces (ezetimibe) and urine (ezetimibe-glucuronide).

What Does Not Affect (Unlike Statins)

Ezetimibe does not inhibit cytochrome P450 (CYP450) enzymes in the liver — the enzymes responsible for metabolizing many drugs. This means ezetimibe has fewer drug interactions than statins, which often interact through CYP3A4. Ezetimibe also does not affect the absorption of fat-soluble vitamins or sex hormones like estradiol — it's highly selective for cholesterol and plant sterols.

For more on ezetimibe's uses and dosing, see: What is ezetimibe? Uses, dosage, and what you need to know in 2026.

If you need help finding ezetimibe at a pharmacy near you, medfinder calls pharmacies on your behalf and texts you which ones have it in stock.